Physician profile
Jeffrey C Lerner
NPI 1962547109
$1,415.62
in general payments reported to CMS, 2019-2025
13 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $457 · 2020: $101 · 2021: $163 · 2022: $98.08 · 2023: $448 · 2024: $15.19 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $536 · Food and Beverage: $60.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $536.00 |
| Food and Beverage | $60.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $536.00 | 2023-2025 | Dr Comfort |
| Rikco International, LLC | $263.00 | 2019-2021 | |
| Treace Medical Concepts, INC. | $252.71 | 2019 | |
| Cook Medical LLC | $104.49 | 2019 | |
| Smith+Nephew, INC. | $48.78 | 2021-2022 | |
| Nevro Corp. | $38.37 | 2022-2023 | Senza |
| Acera Surgical, INC. | $37.64 | 2022 | |
| Horizon Therapeutics Plc | $35.21 | 2019-2021 | |
| Abbvie INC. | $25.27 | 2021 | |
| Novo Nordisk INC | $24.45 | 2022 | |
| Abbott Laboratories | $21.68 | 2025 | Proclaim |
| Organogenesis INC. | $15.19 | 2024 | Apligraf |
| Orthofix Medical, INC. | $12.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lerner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.